Answers are grounded in this paper and cite their sources.
An efficient bimetallic metal-organic framework (MOF) catalyst for the direct synthesis of DMC from from carbon dioxide (CO 2 ) and methanol (CH 3 OH). Using zirconium chloride octahydrate, cerium nitrate hexahydrate, and 1,3,5-benzenetricarboxylic as precursors, MOF-808 with cerium-zirconium bimetallic centers (Ce/Zr-MOF-808) was readily synthesized via a one-pot hydrothermal method. Detailed characterization of Ce/Zr-MOF-808 revealed it retained the octahedral structure of MOF-808, featuring Lewis acid/base sites and the coexistence of Ce 3+ /Ce 4+ . Ce doping enhanced the catalytic activity of Ce/Zr-MOF-808, which exhibited promising activity and excellent stability for the conversion of CO 2 into DMC. The selectivity for DMC reached 94.24%, with 5.56% conversion of CH 3 OH and 5.24% yield of DMC. After four cycles, the yield of DMC slightly decreased from 5.24% to 4.13%, retaining 78.8% of the initial activity. The reasons for the decline in the catalytic performance were revealed, it was primarily caused by the deposition of carbon-containing compounds on the catalyst surface during the reaction process. Based on investigation on the roles of acid-base sites of Ce/Zr-MOF-808 and in situ infrared, A potential reaction mechanism for the direct synthesis of DMC from CO 2 and CH 3 OH over Ce/Zr-MOF-808 was proposed in which both Lewis acid and base active sites play crucial roles.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: